- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
GeneDx Holdings Corp (WGS)
GeneDx Holdings Corp stock price live, this page displays NASDAQ WGS stock exchange data. View the WGS premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the GeneDx Holdings Corp real time stock price chart below.
What Is the GeneDx Holdings Corp Stock Price Today?
The GeneDx Holdings Corp stock price today is 129.19.
What Is the Stock Symbol for GeneDx Holdings Corp?
The stock symbol for GeneDx Holdings Corp is ""WGS.""
What Stock Exchange Does GeneDx Holdings Corp Trade On?
GeneDx Holdings Corp is listed and trades on the NASDAQ stock exchange.
Is GeneDx Holdings Corp a Good Stock to Buy?
Determining whether GeneDx Holdings Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the WGS quote. (ISIN: US81663L2007)
What Is the GeneDx Holdings Corp Stock Price Today?
The GeneDx Holdings Corp stock price today is 129.19.
What Is the Stock Symbol for GeneDx Holdings Corp?
The stock symbol for GeneDx Holdings Corp is ""WGS.""
What Stock Exchange Does GeneDx Holdings Corp Trade On?
GeneDx Holdings Corp is listed and trades on the NASDAQ stock exchange.
Is GeneDx Holdings Corp a Good Stock to Buy?
Determining whether GeneDx Holdings Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the WGS quote. (ISIN: US81663L2007)
NASDAQ
Currency in USD
Fair Value
An estimate of a GeneDx Holdings's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
124.22
130.34
52 wk Range
28.86
130.34
WGS Scorecard
Full Analysis
Net income is expected to grow this year
Trading near 52-week High
1/2
Fair Value
An estimate of a GeneDx Holdings's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
124.22130.34
52 wk Range
28.86130.34
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
WGS Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a GeneDx Holdings's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
115.29
Downside
-10.76%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
4 analysts have revised their earnings upwards for the upcoming period
- CM Life Sciences receives Investment Bank Analyst Rating Update
- Investing.com
Pro - CM Life Sciences receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
GeneDx Holdings Corp Company Profile
GeneDx Holdings Corp., a genomics company, provides genetic testing services. It primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. The company also develops an AI-based platform for NGS analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. The company is headquartered in Stamford, Connecticut.
GeneDx Holdings Corp Earnings Call Summary for Q2/2025
- GeneDx Q2 2025 EPS of $0.50 beat $0.12 forecast; revenue of $102.7M exceeded $85.45M estimate; stock surged 24.36% pre-market
- 49% YoY revenue growth; record 71% adjusted gross margin; exome and genome revenues up 69% YoY; fourth consecutive profitable quarter
- Full-year revenue guidance set at $400M-$415M; exome and genome revenue expected between $345M-$355M; 30%+ volume growth anticipated
- CEO highlights leadership in rare disease diagnosis; focus on early genetic information delivery and proactive healthcare approach
- Expansion plans include pediatric market growth by 2026; NICU testing implementation; potential challenges with Medicaid billing noted
Last Updated: 29/07/2025, 15:30
Read Full TranscriptCompare WGS to Peers and Sector
Metrics to compare | WGS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipWGSPeersSector | |
|---|---|---|---|---|
P/E Ratio | 2,640.5x | −0.6x | −0.5x | |
PEG Ratio | 25.52 | 0.00 | 0.00 | |
Price/Book | 13.4x | 1.0x | 2.6x | |
Price / LTM Sales | 10.2x | 1.2x | 3.3x | |
Upside (Analyst Target) | −6.5% | 38.6% | 38.7% | |
Fair Value Upside | Unlock | 4.0% | 5.0% | Unlock |
Analyst Ratings
6 Buy
1 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 115.29
(-10.76% Downside)
Earnings
Latest Release
Jul 29, 2025
EPS / Forecast
0.50 / 0.12
Revenue / Forecast
102.70M / 85.45M
People Also Watch
FAQ
What Stock Exchange Does GeneDx Holdings Trade On?
GeneDx Holdings is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for GeneDx Holdings?
The stock symbol for GeneDx Holdings is "WGS."
What Is the GeneDx Holdings Market Cap?
As of today, GeneDx Holdings market cap is 3.71B.
What Is GeneDx Holdings's Earnings Per Share (TTM)?
The GeneDx Holdings EPS (TTM) is 0.05.
When Is the Next GeneDx Holdings Earnings Date?
GeneDx Holdings will release its next earnings report on 16 Nov 2025.
From a Technical Analysis Perspective, Is WGS a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has GeneDx Holdings Stock Split?
GeneDx Holdings has split 1 times.
How Many Employees Does GeneDx Holdings Have?
GeneDx Holdings has 1000 employees.
What is the current trading status of GeneDx Holdings (WGS)?
As of 27 Aug 2025, GeneDx Holdings (WGS) is trading at a price of 129.19, with a previous close of 126.25. The stock has fluctuated within a day range of 124.22 to 130.34, while its 52-week range spans from 28.86 to 130.34.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.